- Home
- ASR vs GKOS Comparison
ASR vs GKOS Comparison
Compare ASR & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASR
- GKOS
- Stock Information
- Founded
- ASR 1996
- GKOS 1998
- Country
- ASR Mexico
- GKOS United States
- Employees
- ASR N/A
- GKOS N/A
- Industry
- ASR Aerospace
- GKOS Medical/Dental Instruments
- Sector
- ASR Consumer Discretionary
- GKOS Health Care
- Exchange
- ASR Nasdaq
- GKOS Nasdaq
- Market Cap
- ASR 7.8B
- GKOS 7.4B
- IPO Year
- ASR 2000
- GKOS 2015
- Fundamental
- Price
- ASR $276.05
- GKOS $146.88
- Analyst Decision
- ASR Buy
- GKOS Strong Buy
- Analyst Count
- ASR 4
- GKOS 13
- Target Price
- ASR $274.00
- GKOS $143.00
- AVG Volume (30 Days)
- ASR 48.6K
- GKOS 496.0K
- Earning Date
- ASR 10-22-2024
- GKOS 11-04-2024
- Dividend Yield
- ASR 6.44%
- GKOS N/A
- EPS Growth
- ASR 23.91
- GKOS N/A
- EPS
- ASR 2.16
- GKOS N/A
- Revenue
- ASR $1,490,558,036.00
- GKOS $360,347,000.00
- Revenue This Year
- ASR $18.66
- GKOS $22.68
- Revenue Next Year
- ASR $17.41
- GKOS $24.98
- P/E Ratio
- ASR $12.85
- GKOS N/A
- Revenue Growth
- ASR 11.33
- GKOS 18.70
- 52 Week Low
- ASR $248.88
- GKOS $74.75
- 52 Week High
- ASR $357.90
- GKOS $147.65
- Technical
- Relative Strength Index (RSI)
- ASR 58.87
- GKOS 58.40
- Support Level
- ASR $258.00
- GKOS $137.60
- Resistance Level
- ASR $278.77
- GKOS $147.50
- Average True Range (ATR)
- ASR 6.53
- GKOS 4.74
- MACD
- ASR 1.88
- GKOS 0.45
- Stochastic Oscillator
- ASR 89.00
- GKOS 87.80
About ASR Grupo Aeroportuario del Sureste S.A. de C.V.
Grupo Aeroportuario del Sureste SAB de CV operates airports in southeast Mexico. The company's segments include Cancun; Aerostar; Airplan; Merida; Villahermosa; Holding and Services and other. It generates maximum revenue from the Cancun segment.
About GKOS Glaukos Corporation
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.